Stay updated on Pembrolizumab with Radiation in Hodgkin Lymphoma Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab with Radiation in Hodgkin Lymphoma Clinical Trial page.
Latest updates to the Pembrolizumab with Radiation in Hodgkin Lymphoma Clinical Trial page
- Check6 days agoChange DetectedThe website has been updated from version 2.14.0 to 2.14.1.SummaryDifference0.1%
- Check13 days agoChange DetectedThe website has updated the 'type of intervention' feature from version 2.13.3 to 2.14.0, indicating a significant change in this functionality.SummaryDifference0.2%
- Check20 days agoNo Change Detected
- Check27 days agoNo Change Detected
- Check35 days agoNo Change Detected
- Check42 days agoChange DetectedThe website has been updated from version 2.13.2 to 2.13.3.SummaryDifference0.1%
- Check49 days agoChange DetectedThe study status has changed from 'Recruiting' to 'Active, not recruiting', and the contact details for study inquiries have been updated to provide new information on where the study is taking place.SummaryDifference7%
- Check64 days agoChange DetectedSeveral key resources related to lymphoma and rare diseases have been removed, including links to MedlinePlus and NIH, which may impact access to important health information.SummaryDifference4%
- Check71 days agoChange DetectedNew resources related to lymphoma and Hodgkin lymphoma have been added, including links to MedlinePlus, NIH, and DailyMed, which may provide valuable information for users interested in these conditions.SummaryDifference0.5%
Stay in the know with updates to Pembrolizumab with Radiation in Hodgkin Lymphoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab with Radiation in Hodgkin Lymphoma Clinical Trial page.